Volume 23, Number 7—July 2017
Research
Case−Control Study of Risk Factors for Meningococcal Disease in Chile
Andrea Olea
, Isabel Matute, Claudia González, Iris Delgado, Lucy Poffald, Elena Pedroni, Tania Alfaro, Macarena Hirmas, Manuel Nájera, Ana Gormaz, Darío López, Sergio Loayza, Catterina Ferreccio, Doris Gallegos, Rodrigo Fuentes, Pablo Vial, and Ximena Aguilera
, Isabel Matute, Claudia González, Iris Delgado, Lucy Poffald, Elena Pedroni, Tania Alfaro, Macarena Hirmas, Manuel Nájera, Ana Gormaz, Darío López, Sergio Loayza, Catterina Ferreccio, Doris Gallegos, Rodrigo Fuentes, Pablo Vial, and Ximena Aguilera
Table 4
Multivariate model of risk factors for development of meningococcal disease in persons >5 years of age for all Neisseria meningitidis serogroups, Chile, January 2012−March 2013*
| Risk factor |
β |
SE |
p value |
OR (95% CI) |
| Overcrowding | 1.61 | 0.50 | 0.001 | 5.01 (1.87–13.45) |
| Lived in crowded places | 1.51 | 0.66 | 0.022 | 4.54 (1.24–16.67) |
| Used corticoids | 1.46 | 0.57 | 0.011 | 4.29 (1.39–13.21) |
| Person 14 y of age consuming >4 alcoholic drinks | 1.30 | 0.41 | 0.001 | 3.68 (1.66–8.19) |
| Nonrespiratory chronic disease | 1.20 | 0.36 | 0.001 | 3.32 (1.64–6.73) |
| Hospitalization for asthma or acute lower RTI | 1.08 | 0.49 | 0.028 | 2.94 (1.12–7.71) |
| Constant |
−6.73 |
1.69 |
<0.001 |
0.00 |
| *OR, odds ratio; RTI, respiratory tract infection; R2 = 19%. | ||||
Page created: June 19, 2017
Page updated: June 19, 2017
Page reviewed: June 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.